Article

Community Nonpharmacological Osteoarthritis Care Uneven and Suboptimal

For patients with knee or hip osteoarthritis, the quality of nonpharmacological care in the community is less than optimal.

For patients with knee or hip osteoarthritis, the quality of nonpharmacological care in the community is less than optimal. The provision of advice to patients on exercise and weight management may be inequitable between the sexes, among age groups, and at various disability and formal education levels.

Li and colleagues mailed a survey questionnaire to evaluate the following quality-of-care indicators: (1) advice to exercise; (2) advice to lose weight; (3) assessment for ambulatory function; and (4) assessment for nonambulatory function, including dressing, grooming, and arising from sitting to standing. Function was measured with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score.

The overall pass rate of the indicators was 22.4%. The pass rate for individual indicators ranged from 6.9% for receiving assessment of nonambulatory function to 29.2% for receiving assessment of ambulatory function. Receiving exercise advice was associated with having a university degree. Receiving weight loss advice was associated with being a woman, being age 55 to 64 years, and having higher WOMAC scores. However, the chances of receiving weight loss advice were reduced with having less than a high school education.

The authors noted that identifying barriers to providing advice on exercise and healthy weight is needed.

 

Problems with / comments about this article? Please send feedback.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.